Friday, August 22, 2025

Tesla: Canaccord Lowers Target To $812 Off 4680 Cell Delay

Tesla Inc (NASDAQ: TSLA) founder Elon Musk has been in the news quite a bit recently with him trolling the crypto investors, flip-flopping his and the company’s stance on crypto, and accepting crypto. Nonetheless, Elon took to Twitter last week to announce that the Plaid+ is canceled. Telsa had a Plaid debut event at the Fermont Factory last week.

Tesla currently has 37 analysts covering the name with a weighted 12-month price target of $652.52, with eight analysts having strong buy ratings, and six analysts having buy ratings. 13 analysts have hold ratings, six have sell ratings and four have strong sell ratings. Elazar Advisors has the street high of $1,471 while GLJ Research has the lowest price target at $67.

Canaccord reiterated their buy rating for Tesla but lowered their 12-month price target from $974 to $812 to reflect the firms 4680 cell debut delay. Their analyst Jed Dorsheimer calls Tesla’s $130k Model S Plaid, “ostensibly unnecessary.” But he continues to believe that Tesla is the innovator while all other OEMs are still playing catch up.

The most recent innovation by Tesla was announced at this unveiling, where they say that they have a machine that can wind copper rotors at a higher tension, which reportedly allows the wires to have a more efficient electromagnetic field. Dorsheimer says, “We expect this to lead to industry-wide improvements in motor design.”

The main reason why Canaccord believes that the Model S Plaid+ was delayed is due to a production delay in the companies new 4680 cells. He writes, “This signals to us the new cell format isn’t ready for production just yet, and cell production capacity constraints for energy storage products like Powerwall remain.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

Why Grade Beats Size in Silver Mining | Frank Basa – Nord Precious Metals

Are Investors Missing the Start of the Next Commodity Supercycle? | Morgan Lekstrom – NexMetals

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

Tesla Taking A Hit As Elon Musk Focuses On Twitter

Tesla stock has dropped 28% since October 27, when CEO Elon Musk purchased and took...

Wednesday, December 14, 2022, 02:00:00 PM

Curaleaf Consensus Target Remains Flat After Record Quarter

On August 9, Curaleaf Holdings (CSE: CURA) reported record second quarter financial results. The company...

Tuesday, August 17, 2021, 11:43:00 AM

Tesla Model Y Is Now Cheaper Than The Average New Car In The US

Last week, Tesla (Nasdaq: TSLA) cut US prices for the fifth time for the Model...

Thursday, April 27, 2023, 06:19:00 AM

Couche-Tard: Canaccord Reiterates $51 Price Target After Q3 Results

On November 23rd, Alimentation Couche-Tard Inc. (TSX: ATD.B) announced its fiscal second quarter results. The...

Friday, November 26, 2021, 04:32:00 PM

Green Thumb Sees Consensus Estimate Fall To $49.89 After Q4 Earnings

Earlier this week, Green Thumb Industries (CSE: GTII) reported its fourth quarter financial results. The...

Thursday, March 3, 2022, 04:31:00 PM